Status:
COMPLETED
Hyzaar Asia HEAALTH (0954A-950)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The objective of the study is to estimate the percentage of patients who reach blood pressure goal after 8 weeks of treatment with losartan/HCTZ combination.
Eligibility Criteria
Inclusion
- Patient is male or female and = 18 years of age
- Patients with essential hypertension previously treated with antihypertensive medications for at least 4 weeks but did not reach the blood pressure goal
Exclusion
- History of any condition, therapy, lab abnormality or other circumstance that might confound the results of the study, or interfere with the patient's participation for the full duration of the study, such that it is not in the best interest of the patient/subject to participate
- Pregnant or breastfeeding, or expecting to conceive within the projected duration of the study
- Previous history of severe essential hypertension
- History of stroke or myocardial infarction (heart attack)
- Evidence of renal or liver disease
- Uncontrolled diabetes mellitus
- Any known bleeding disorder
- Known sensitivity or intolerance to the study medication (losartan or hydrochlorothiazide)
- Other antihypertensive medications or medications that may affect blood pressure
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2007
Estimated Enrollment :
437 Patients enrolled
Trial Details
Trial ID
NCT00354991
Start Date
June 1 2006
End Date
April 1 2007
Last Update
May 9 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.